Summit Partners Public Asset Management’s Guardant Health GH Stock Holding History

Summit Partners Public Asset Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-350,000	Closed	-$32.3M	–	186
2026 Q1	$32.3M	Buy	+350,000	New	+$35.1M	0.87%	39
2020 Q2	–	Sell	-99,800	Closed	-$6.95M	–	107
2020 Q1	$6.95M	Buy	+99,800	New	+$7.66M	0.57%	49
2019 Q4	–	Sell	-120,000	Closed	-$7.66M	–	89
2019 Q3	$7.66M	Buy	+120,000	New	+$10.6M	0.75%	58

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Summit Partners Public Asset Management's GH Position: Q2 2026 in Review

Summit Partners Public Asset Management increased its Guardant Health (GH) stake by 12% in Q2 2026, buying an estimated $11.4M and bringing the position to 967,697 shares worth $145M. The position accounts for 2.55% of the portfolio, ranked #3.

Summit Partners Public Asset Management first reported a position in GH in Q2 2019 and has held it in 11 quarters since. 600 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Summit Partners Public Asset Management held 967,697 shares of Guardant Health worth $145M as of Q2 2026.
Summit Partners Public Asset Management bought 104,782 Guardant Health shares in Q2 2026, an estimated $11.4M.
Guardant Health made up 2.55% of Summit Partners Public Asset Management's portfolio in Q2 2026, its #3 holding.
Summit Partners Public Asset Management first reported a position in Guardant Health in Q2 2019 and has held it in 11 quarters since.
600 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Summit Partners Public Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.